MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers.

作者: Ali Nazarizadeh , Forogh Mohammadi , Fatemeh Alian , Parisa Faraji , Mitra Nourbakhsh

DOI: 10.2147/OTT.S249268

关键词: GeneDiseaseGene expressionCancer researchCarcinogenesismicroRNACancerBiologyOncogeneSuppressor

摘要: MicroRNAs (miRNAs) are endogenous, non-coding, single-stranded, tiny RNAs with 21-23 nucleotides that regulate several biological functions through binding to target mRNAs and modulating gene expression at post-transcriptional levels. Recent studies have described crucial roles for miRNAs in pathophysiology of numerous human cancers. They can act as an oncogene promote cancer or a tumor suppressor alleviate the disease. Recently discovered microRNA-154 (miR-154) has been proposed be involved multiple physiological pathological processes including cancer. With this aspect, aberrant miR-154 demonstrated variety malignancies, suggesting important role tumorigenesis. To specific, it is considered miRNA exerts its beneficial effects by targeting genes. This review systematically summarizes recent advances done on different cancers discusses potential prognostic, diagnostic therapeutic values.

参考文章(77)
David S. Geller, Richard Gorlick, Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clinical advances in hematology & oncology. ,vol. 8, pp. 705- 718 ,(2010)
Xiaoli Pang, Kexin Huang, Qianqian Zhang, Yujiao Zhang, Junqi Niu, miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor Oncology Reports. ,vol. 34, pp. 3272- 3279 ,(2015) , 10.3892/OR.2015.4321
M. H. van der Ree, A. J. van der Meer, A. C. van Nuenen, J. de Bruijne, S. Ottosen, H. L. Janssen, N. A. Kootstra, H. W. Reesink, Miravirsen dosing in chronic hepatitis C patients results in decreased microRNA‐122 levels without affecting other microRNAs in plasma Alimentary Pharmacology & Therapeutics. ,vol. 43, pp. 102- 113 ,(2016) , 10.1111/APT.13432
XINGYU LIN, ZHIGUANG YANG, PENG ZHANG, GUOGUANG SHAO, miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo Oncology Reports. ,vol. 33, pp. 3053- 3060 ,(2015) , 10.3892/OR.2015.3895
P.J. Miranda, S. Vimalraj, N. Selvamurugan, A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells. International Journal of Biological Macromolecules. ,vol. 72, pp. 145- 150 ,(2015) , 10.1016/J.IJBIOMAC.2014.07.051
Shuai Li, Huimin Meng, Feng Zhou, Lili Zhai, Lina Zhang, Feng Gu, Yu Fan, Ronggang Lang, Li Fu, Lin Gu, Liqiang Qi, MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathology Research and Practice. ,vol. 209, pp. 179- 183 ,(2013) , 10.1016/J.PRP.2012.12.002
Lisa Mirabello, Rebecca J. Troisi, Sharon A. Savage, Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program Cancer. ,vol. 115, pp. 1531- 1543 ,(2009) , 10.1002/CNCR.24121
Caterina Mian, Gianmaria Pennelli, Matteo Fassan, Mariangela Balistreri, Susi Barollo, Elisabetta Cavedon, Francesca Galuppini, Marco Pizzi, Federica Vianello, Maria Rosa Pelizzo, Maria Elisa Girelli, Massimo Rugge, Giuseppe Opocher, None, MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid. ,vol. 22, pp. 890- 896 ,(2012) , 10.1089/THY.2012.0045
Riccardo Cazzoli, Fiamma Buttitta, Marta Di Nicola, Sara Malatesta, Antonio Marchetti, William N. Rom, Harvey I. Pass, microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer Journal of Thoracic Oncology. ,vol. 8, pp. 1156- 1162 ,(2013) , 10.1097/JTO.0B013E318299AC32